According to @WhiteHouse, President Biden has unveiled a comprehensive plan to reduce prescription drug prices, specifically targeting Medicare, low-income patients, and increasing the availability of generics and biosimilars. This initiative could lead to significant cost savings for consumers and impact pharmaceutical stocks.